<SEC-DOCUMENT>0000950103-25-013389.txt : 20251020
<SEC-HEADER>0000950103-25-013389.hdr.sgml : 20251020
<ACCEPTANCE-DATETIME>20251020135530
ACCESSION NUMBER:		0000950103-25-013389
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251020
DATE AS OF CHANGE:		20251020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251403279

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251403280

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236071_424b2-us2522625d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt">The
    information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these
    securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product
    supplement, prospectus supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy
    these securities, in any state where the offer or sale is not permitted.</FONT></P>
    <P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="color: red; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt">SUBJECT
    TO COMPLETION, DATED OCTOBER 20, 2025</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%"><P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">October&nbsp;&nbsp;&nbsp;&nbsp;
    , 2025</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Medium-Term
    Senior Notes, Series N</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Pricing
    Supplement No. 2025-USNCH29014</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed
    Pursuant to Rule 424(b)(2)</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration
    Statement Nos. 333-270327 and 333-270327-01</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(89,174,67)">Barrier Securities Linked to Microsoft Corporation Due
November 2, 2026</P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured
debt securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. Unlike conventional debt securities,
the securities do not pay interest and do not repay a fixed amount of principal at maturity. Instead, the securities offer a payment
at maturity that may be greater than, equal to or less than the stated principal amount, depending on the performance of the underlying
specified below from the initial underlying value to the final underlying value.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offer modified exposure to the performance of
the underlying, with (i) the opportunity to participate in a limited range of potential appreciation of the underlying at the upside
participation rate specified below and (ii) contingent repayment of the stated principal amount at maturity if the underlying depreciates,
<B>but only</B> so long as the final underlying value is greater than or equal to the final barrier value specified below. In exchange
for these features, investors in the securities must be willing to forgo any appreciation of the underlying in excess of the maximum
return at maturity specified below and must be willing to forgo any dividends with respect to the underlying. In addition, investors
in the securities must be willing to accept full downside exposure to the depreciation of the underlying if the final underlying value
is less than the final barrier value. <B>If the final underlying value is less than the final barrier value, you will not be repaid the
stated principal amount of your securities at maturity and, instead, will receive underlying shares of the underlying (or, in our sole
discretion, cash based on the value thereof) that will be worth significantly less than your initial investment and possibly worth nothing.
You may lose your entire investment in the securities.</B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>In order to obtain the modified exposure to the underlying that
the securities provide, investors must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk
of not receiving any amount due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="4"><FONT STYLE="color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Microsoft Corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Strike date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 17, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 30, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 23, 2026, subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 2, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You will receive at maturity for each security you then hold:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-size: 10pt">&nbsp;If
    the final underlying value is <B>greater than</B> the initial underlying value:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000 + the return amount, subject to the maximum return
    at maturity</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-size: 10pt">&nbsp;If
    the final underlying value is <B>less than or equal to</B> the initial underlying value but <B>greater than or equal to</B> the final
    barrier value:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-size: 10pt">&nbsp;If
    the final underlying value is <B>less than</B> the final barrier value:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">a fixed number of underlying shares of the underlying equal
    to the equity ratio (or, if we elect, the cash value of those shares based on the final underlying value)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the final underlying value is less than the final barrier
value, you will receive underlying shares (or, in our sole discretion, cash) that will be worth significantly less than the stated principal
amount of your securities, and possibly nothing, at maturity.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$513.58, the closing value of the underlying on the strike date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$462.222, 90.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Equity ratio:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">1.94712, the stated principal amount <I>divided</I> by the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Return amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 &times; the underlying return &times; the upside participation rate</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Upside participation rate:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">150.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">(i) The final underlying value <I>minus</I> the initial underlying value, <I>divided by</I> (ii) the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maximum return at maturity:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The maximum return at maturity will be 225.80 per security (22.58% of the stated principal amount). The payment at maturity per security will not exceed the stated principal amount plus the maximum return at maturity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">17333MSC8 / US17333MSC81</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$15.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$985.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(1) Citigroup Global Markets Holdings
Inc. currently expects that the estimated value of the securities on the pricing date will be at least $927.00 per security, which will
be less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s proprietary pricing models and our internal
funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any,
at which CGMI or any other person may be willing to buy the securities from you at any time after issuance. See &ldquo;Valuation of the
Securities&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">(2) For more information on the distribution
of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee,
CGMI and its affiliates may profit from expected hedging activity related to this offering, even if the value of the securities declines.
See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-5.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, prospectus supplement and prospectus are truthful or complete. Any representation
to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="color: #59AE43"><B>Product Supplement No. EA-02-10 dated March 7, 2023</B></FONT></A>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="color: #59AE43"><B>Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General.</B> The terms of the securities are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of the underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to the underlying. It is important that you read the accompanying product supplement, prospectus supplement and prospectus
together with this pricing supplement in deciding whether to invest in the securities. Certain terms used but not defined in this pricing
supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Closing Value.</B> The &ldquo;closing value&rdquo; of the underlying
on any date is the closing price of its underlying shares on such date, as provided in the accompanying product supplement. The &ldquo;underlying
shares&rdquo; of the underlying are its shares of common stock. Please see the accompanying product supplement for more information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Payout Diagram</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram below illustrates the value of what you would receive at
maturity for a range of hypothetical underlying returns. For purposes of the diagram, the value of any underlying shares you receive at
maturity is based on the final underlying value, which is the closing value of the underlying on the valuation date. On the maturity date,
the value of any underlying shares you receive may differ from their value on the valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends with respect
to the underlying. The diagram and examples below do not show any effect of lost dividend yield over the term of the securities.</B> See
&ldquo;Summary Risk Factors&mdash;You will not receive dividends or have any other rights with respect to the underlying unless and until
you receive underlying shares of the underlying at maturity&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD COLSPAN="2" STYLE="border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Payout Diagram</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 406px; width: 678px"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-left: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: right"><FONT STYLE="font-family: Wingdings; color: #59AE43">n</FONT> The Securities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: #59AE43 1pt solid; border-right: #59AE43 1pt solid; text-align: left"><FONT STYLE="font-family: Wingdings">n</FONT> The Underlying</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate how to determine the payment at maturity
on the securities, assuming the various hypothetical final underlying values indicated below. The examples are solely for illustrative
purposes, do not show all possible outcomes and are not a prediction of what the actual payment at maturity on the securities will be.
The actual payment at maturity will depend on the actual final underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying value, final barrier value or equity ratio. For the actual initial underlying value, final
barrier value and equity ratio, see the cover page of this pricing supplement. We have used these hypothetical values, rather than the
actual values, to simplify the calculations and aid understanding of how the securities work. However, you should understand that what
you actually receive at maturity will be determined based on the actual initial underlying value, final barrier value and equity ratio,
and not the hypothetical values indicated below. For ease of analysis, figures below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="width: 31%; border: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical initial underlying value:</B></FONT></TD>
    <TD STYLE="width: 69%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">$100.00</TD></TR>
  <TR>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical final barrier value:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">$90.00 (90.00% of the hypothetical initial underlying value)</TD></TR>
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical equity ratio:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">10.00000 (the stated principal amount divided by the hypothetical initial underlying value)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1&mdash;Upside Scenario A.</B> The final underlying value
is $105.00, resulting in a 5.00% underlying return. In this example, the final underlying value is <B>greater than</B> the initial underlying
value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the return amount, subject
to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; the underlying return &times; the upside
participation rate), subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; 5.00% &times; 150.00%), subject to the maximum
return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $75.00, subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,075.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has appreciated from the initial underlying
value to the final underlying value, and the underlying return <I>multiplied by</I> the upside participation rate is less than the maximum
return at maturity. As a result, your total return at maturity would equal the underlying return <I>multiplied by</I> the upside participation
rate.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Upside Scenario B.</B> The final underlying value
is $180.00, resulting in an 80.00% underlying return. In this example, the final underlying value is <B>greater than</B> the initial underlying
value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the return amount, subject
to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; the underlying return &times; the upside
participation rate), subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; 80.00% &times; 150.00%), subject to the
maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $1,200.00, subject to the maximum return at maturity</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,225.80</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has appreciated from the initial underlying
value to the final underlying value, but the underlying return <I>multiplied by</I> the upside participation rate would exceed the maximum
return at maturity. As a result, your total return at maturity in this scenario would be limited to the maximum return at maturity, and
an investment in the securities would underperform a hypothetical alternative investment providing 1-to-1 exposure to the appreciation
of the underlying without a maximum return.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Par Scenario.</B> The final underlying value is $95.00,
resulting in a -5.00% underlying return. In this example, the final underlying value is <B>less than</B> the initial underlying value
but <B>greater than</B> the final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has depreciated from the initial underlying
value to the final underlying value but not below the final barrier value. As a result, you would be repaid the stated principal amount
of your securities at maturity but would not receive any positive return on your investment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 4&mdash;Downside Scenario A.</B> The final underlying value
is $30.00, resulting in a -70.00% underlying return. In this example, the final underlying value is <B>less than</B> the final barrier
value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">What you would receive at maturity per security = A number of underlying
shares of the underlying equal to the equity ratio (or, in our sole discretion, cash in an amount equal to the equity ratio &times; the
final underlying value)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= 10 underlying shares of the underlying, with an aggregate cash value
(based on the final underlying value) of $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has depreciated from the initial underlying
value to the final underlying value and the final underlying value is less than the final barrier value. As a result, you would not be
repaid the stated principal amount of your securities at maturity but, instead, would receive a number of underlying shares of the underlying
(or, in our sole discretion, cash based on the value thereof) worth significantly less than your initial investment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the final underlying value of the underlying is less than the final
barrier value, we will have the option to deliver to you on the maturity date either a number of underlying shares of the underlying equal
to the equity ratio or the cash value of those underlying shares based on their final underlying value. The value of those underlying
shares on the maturity date may be different than their final underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 5&mdash;Downside Scenario B.</B> The final underlying value
is $0.00, resulting in a -100.00% underlying return. In this example, the final underlying value is <B>less than</B> the final barrier
value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying shares of the underlying are worthless
on the valuation date and, as a result, you would lose your entire investment in the securities at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the final underlying value of the underlying
will be less than the final barrier value, such that you will receive significantly less than the stated principal amount of your securities,
and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with the underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not repay
a fixed amount of principal at maturity. Instead, your payment at maturity will depend on the performance of the underlying. If the final
underlying value is less than the final barrier value, you will not be repaid the stated principal amount of your securities at maturity
but, instead, will receive underlying shares of the underlying (or, in our sole discretion, cash based on the value thereof) that will
be worth significantly less than your initial investment in the securities and may be worth nothing. There is no minimum payment at maturity
on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">We may elect, in our sole discretion, to
pay you cash at maturity in lieu of delivering any underlying shares of the underlying. If we elect to pay you cash at maturity in lieu
of delivering any underlying shares of the underlying, the amount of that cash may be less than the market value of the underlying shares
on the maturity date because the market value will likely fluctuate between the valuation date and the maturity date. Conversely, if we
do not exercise our cash election right and instead deliver underlying shares of the underlying to you on the maturity date, the market
value of such underlying shares may be less than the cash amount you would have received if we had exercised our cash election right.
We will have no obligation to take your interests into account when deciding whether to exercise our cash election right.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The initial underlying value, set on the strike date, may be higher than the closing value of the underlying on the pricing date.</B>
If the closing value of the underlying on the pricing date is less than the initial underlying value set on the strike date, the terms
of the securities may be less favorable to you than the terms of an alternative investment that may be available to you that offers a
similar payout as the securities but with the initial underlying value set on the pricing date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B> Unlike conventional debt securities, the securities do not pay interest or any other amounts
prior to maturity. You should not invest in the securities if you seek current income during the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your potential return on the securities is limited.</B> Your potential total return on the securities at maturity is limited to
the maximum return at maturity, even if the underlying appreciates by significantly more than the maximum return at maturity. If the underlying
appreciates by more than the maximum return at maturity, the securities will underperform an alternative investment providing 1-to-1 exposure
to the performance of the underlying. When lost dividends are taken into account, the securities may underperform an alternative investment
providing 1-to-1 exposure to the performance of the underlying even if the underlying appreciates by less than the maximum return at maturity.
In addition, the maximum return at maturity reduces the effect of the upside participation rate for all final underlying values exceeding
the final underlying value at which, by multiplying the corresponding underlying return by the upside participation rate, the maximum
return at maturity is reached.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive dividends or have any other rights with respect to the underlying unless and until you receive underlying
shares of the underlying at maturity. </B>You will not receive any dividends with respect to the underlying unless and until you receive
underlying shares of the underlying at maturity. This lost dividend yield may be significant over the term of the securities. The payment
scenarios described in this pricing supplement do not show any effect of lost dividend yield over the term of the securities. In addition,
you will not have voting rights or any other rights with respect to the underlying. If any change to the underlying shares of the underlying
is proposed, such as an amendment to the underlying&rsquo;s organizational documents, you will not have the right to vote on such change,
but you will be subject to such change in the event you receive underlying shares of the underlying at maturity. Any such change may adversely
affect the market value of the underlying shares of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your payment at maturity depends on the closing value of the underlying on a single day.</B> Because your payment at maturity depends
on the closing value of the underlying solely on the valuation date, you are subject to the risk that the closing value of the underlying
on that day may be lower, and possibly significantly lower, than on one or more other dates during the term of the securities. If you
had invested directly in the underlying or in another instrument linked to the underlying that you could sell for full value at a time
selected by you, or if the payment at maturity were based on an average of closing values of the underlying, you might have achieved better
returns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the closing value of the underlying, the dividend
yield on the underlying and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an
underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to
be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities set
forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying,
the dividend yield on the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness,
as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating to the Securities&mdash;Risk
Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based on many unpredictable factors&rdquo;
in the accompanying product supplement. Changes in the closing value of the underlying may not result in a comparable change in the value
of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly less than
the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of the underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlying is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlying or in instruments
related to the underlying, and may publish research or express opinions, that in each case are inconsistent with an investment linked
to the underlying. These and other activities of our affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of the underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may take positions in the underlying
or in financial instruments related to the underlying and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlying or in financial instruments related to the underlying on a regular basis (taking long or short positions
or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities
could affect the closing value of the underlying in a way that negatively affects the value of and your return on the securities. They
could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlying
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to the underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Even if the underlying pays a dividend that it identifies as special or extraordinary, no adjustment will be required under the
securities for that dividend unless it meets the criteria specified in the accompanying product supplement.</B> In general, an adjustment
will not be made under the terms of the securities for any cash dividend paid by the underlying unless the amount of the dividend per
share, together with any other dividends paid in the same quarter, exceeds the dividend paid per share in the most recent quarter by an
amount equal to at least 10% of the closing value of the underlying on the date of declaration of the dividend. Any dividend will reduce
the closing value of the underlying by the amount of the dividend per share. If the underlying pays any dividend for which an adjustment
is not made under the terms of the securities, holders of the securities will be adversely affected. See &ldquo;Description of the Securities&mdash;Certain
Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Dilution and Reorganization Adjustments&mdash;Certain
Extraordinary Cash Dividends&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be adjusted for all events that may have a dilutive effect on or otherwise adversely affect the closing
value of the underlying.</B> For example, we will not make any adjustment for ordinary dividends or extraordinary dividends that do not
meet the criteria described above, partial tender offers or additional underlying share issuances. Moreover, the adjustments we do make
may not fully offset the dilutive or adverse effect of the particular event. Investors in the securities may be adversely affected by
such an event in a circumstance in which a direct holder of the underlying shares would not.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may become linked to an underlying other than the original underlying upon the occurrence of a reorganization event
or upon the delisting of the underlying shares.</B> For example, if the underlying enters into a merger agreement that provides for holders
of the underlying shares to receive shares of another entity and such shares are marketable securities, the closing value of the underlying
following consummation of the merger will be based on the value of such other shares. Additionally, if the underlying shares are delisted,
the calculation agent may select a successor underlying. See &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities
Linked to an Underlying Company or an Underlying ETF&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If the underlying shares are delisted, we may call the securities prior to maturity for an amount that may be less than the stated
principal amount.</B> If we exercise this call right, you will receive the amount described under &ldquo;Description of the Securities&mdash;Certain
Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Delisting of an Underlying Company&rdquo; in
the accompanying product supplement. This amount may be less, and possibly significantly less, than the stated principal amount of the
securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might
not agree with the treatment of the securities as prepaid forward contracts. If the IRS were successful in asserting an alternative treatment
of the securities, the tax consequences of the ownership and disposition of the securities might be materially and adversely affected.
For example, as discussed below, there is a substantial risk that the IRS could seek to treat the securities as debt instruments.&nbsp;&nbsp;Moreover,
future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment of the securities, possibly
retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">If you are a non-U.S. investor, you should review the discussion
of withholding tax issues in &ldquo;United States Federal Tax Considerations&mdash;Non-U.S. Holders&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About Microsoft Corporation</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Microsoft Corporation develops, manufactures, licenses, sells, and supports
software products. The company offers operating system software, server application software, business and consumer applications software,
software development tools, and Internet and intranet software. Microsoft Corporation also develops video game consoles and digital music
entertainment devices. The underlying shares of Microsoft Corporation are registered under the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;). Information provided to or filed with the SEC by Microsoft Corporation pursuant to the Exchange Act
can be located by reference to the SEC file number 001-37845 through the SEC&rsquo;s website at http://www.sec.gov.
In addition, information regarding Microsoft Corporation may be obtained from other sources including, but not limited to, press releases,
newspaper articles and other publicly disseminated documents. The underlying shares of Microsoft Corporation trade on the NASDAQ Global
Select Market under the ticker symbol &ldquo;MSFT.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding Microsoft Corporation from
publicly available information and have not independently verified any information regarding Microsoft Corporation. This pricing supplement
relates only to the securities and not to Microsoft Corporation. We make no representation as to the performance of Microsoft Corporation
over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. Microsoft Corporation is not involved in any way in this offering and has no obligation relating
to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of Microsoft Corporation on October 17, 2025 was $513.58.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of Microsoft Corporation for
each day such value was available from January 2, 2015 to October 17, 2025. We obtained the closing values from Bloomberg L.P., without
independent verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited
to, spin-offs or mergers, then the closing values shown below for the period prior to the occurrence of any such transaction have been
adjusted by Bloomberg L.P. as if any such transaction had occurred prior to the first day in the period shown below. You should not take
historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Microsoft Corporation &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 17, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 351px; width: 644px"></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement. This discussion does not address the U.S. federal tax consequences of the
ownership or disposition of the underlying shares that you may receive at maturity. You should consult your tax adviser regarding the
U.S. federal tax consequences of the ownership and disposition of the underlying shares.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal income tax consequences of an investment in the securities. In the opinion of our counsel, Davis
Polk &amp; Wardwell LLP, it is reasonable under current law to treat a security as a prepaid forward contract for U.S. federal income
tax purposes.&nbsp;&nbsp;However, our counsel has advised us that it is unable to conclude affirmatively that this treatment is more likely
than not to be upheld, and that alternative treatments are possible.&nbsp;&nbsp;Moreover, our counsel&rsquo;s opinion is based on market
conditions as of the date of this preliminary pricing supplement and is subject to confirmation on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity for cash), you should recognize capital gain or loss equal
to the difference between the amount realized and your tax basis in the security. Such gain or loss should be long-term capital gain or
loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If you receive the underlying shares (and cash in lieu of any fractional shares) at maturity, you should not recognize gain or loss
with respect to the underlying shares received.&nbsp;&nbsp;Instead, you should have an aggregate tax basis in the underlying shares received
(including any fractional shares deemed received) equal to your basis in the securities.&nbsp;&nbsp;Your holding period for any underlying
shares received should start on the day after receipt. With respect to any cash received in lieu of a fractional share, you should recognize
capital loss in an amount equal to the difference between the amount of cash received in lieu of the fractional share and the portion
of your tax basis in the securities that is allocable to the fractional share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized.&nbsp;&nbsp;In particular, due to the terms
of the securities, there is a substantial risk that the IRS could seek to treat the securities as debt instruments for U.S. federal income
tax purposes. In that event, you would be required to accrue into income original issue discount on the securities every year at a &ldquo;comparable
yield&rdquo; determined as of the time of issuance and recognize all income and gain in respect of the securities as ordinary income.
In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax
treatment of &ldquo;prepaid forward contracts&rdquo; and similar financial instruments and have indicated that such transactions may be
the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment
of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could
materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should
consult your tax adviser regarding possible alternative tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders.</B> Subject to the discussions below and in &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us as of the date of this preliminary pricing supplement, our counsel
is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning
of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m).
However, the final determination regarding the treatment of the securities under Section 871(m) will be made as of the pricing date for
the securities, and it is possible that the securities will be subject to withholding tax under Section 871(m) based on the circumstances
as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: rgb(89,174,67) 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $15.00 for each security sold
in this offering. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $15.00
for each security they sell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the securities is a function of the terms of
the securities and the inputs to CGMI&rsquo;s proprietary pricing models.&nbsp;&nbsp;As of the date of this preliminary pricing supplement,
it is uncertain what the estimated value of the securities will be on the pricing date because it is uncertain what the values of the
inputs to CGMI&rsquo;s proprietary pricing models will be on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(89,174,67)">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &6 J8# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQL5*N?W:G[Q&PYR0.W>M!/$,4GBDZ&MI<AE@:5KAT*QD@K\JD_>^\,D<#ZT
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MU/%=[;V\-K D,$21QH-JHBA0H] !TJ6B@ HHHH **** "BBB@ HHHH ****
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M^1-T3_KP@_\ 1:UL5C^$_P#D3=$_Z\(/_1:UL4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !0 !T&*** "BBB@ J*YN(K.U
MFN9WV0PHTDC>B@9)_(5+65XF_P"14UC_ *\9O_0#0!IQR++$DB'*. RGU!IU
M5]/&--M1_P!,4_D*L4 %%%% !00#U&:SM:U[2_#NGM?:M>Q6ENO&Z0\L?0#J
M3["N+DUCQ7XYWQZ!$^@Z(PVG4;R$BYF'<Q1_PC'1CS0!T?B3QII/AIHK><RW
M6H3'$-A9IYL\A_W1T'N<"N:&A>*_'2.WB:Z?1-'D/&DV3?O9$XQYTO;/=5KH
M_#/@?1?"X,ME;M)?2#]_>SL9)YCW+.>>?0<5TE &?I&B:;H-BEGIEG#:VZ#A
M(E 'U/J?<UH444 %%%% !1110 4444 %%%% !1110 4444 9OB")9O#VH*TD
M<1^S2%99.D9VG#>V.N:\X^'NLB75[#37OO"5W*D!4RV*.+J3:OWN5 Y[_C7I
MNKRK!HU],UP+=8[=W,Q3>(P%)W;3UQUQWKS+PM$\WC'P[J6K:U=7,MW8SS::
MITN*T5E(&X,4)).W# 'L: /6:*** .&\9>'M4U?6[";3["!98F_=ZG'=&*6#
MY''S #+*"P. 3GH170R:;<MXGLM0RC0PVDL+G.&+LR$''_ 36Q10!P6L^'K[
M6KEM6BTQ3<WEFD*K/<M$UC(I8B08')&_/&#Q[U9;PWJWVI[ B!]/FU"._DNS
M)A\@*639CJ67KG&#7:44 <;I&AZQ9SZ>EQ;V_DZ/!,ENR39-T6P%R"/DPHYZ
M\FEO=!U:;4+VWBBM_L&I74%U+.TOSP[-FY=N/FSL&#D=>>E=C10!Q^E^']4M
M]0TZVN(X%L-,GGFBG60EY]^[:-N/EP'.>3G Q72:G8QW]DT4LMS&H^;-O.\3
M=/52#CVJY3)O]3)_NG^5 &5X2X\&Z'_V#X/_ $6M;%8_A/\ Y$W1/^O"#_T6
MM;% !1110 4444 %%%% !113(IHKB,20RI(A) 9&!'YB@!]%'6FAT*E@RD#J
M0>E #J*:9$";RZ[?7/%.Z#)H **;YB;-^]=G][/%.ZT %%-61&4LKJ0.I!IU
M !10"",@YH) ZG% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !65XF_Y%75_^O*;_ - -:M9/
MBCCPIJW_ %Z2?^@F@"_9<6%N/^F2_P A4]0VG%G /^F:_P JYWQ)X[TKP]<Q
M:>HEU'5YCMATZR >9CZD?PCW.* .G9E12S,%4#)). *X;4/B$;^^?2O!=DNN
MWZ?ZZ<2;+6VY'WY/XN_"YZ54_P"$7\1>-R9?&%U)I^EN05T.RD&&7C_72CEN
M>PP!7=:=IEEI-G'::?:Q6UO&,+%$@51^ H Y+0_ &^^37/%MT-9UP'<CLN(+
M;T6*/H,?WB,UVX&!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!3U>5(-%OII;8W,:6\C- !DR@*<K^/2O$?A/K&F77C&&*'38VN6258?+NY
M9UL8/+1P%#G"@D[#C'(QTKU;QU+K</A>5] 6<W8ECW_9T5Y1%O&\QJW!;;G
MKC/!MKXHC\:V^HW=M=6T&I+<37=J\")';P@@0*2!_K2021GH: /5Z*** "BL
M34_%FEZ3JD&G7+3M/+@MY4+.L0()!<@?*#M/Y>G-71K.G-K/]D+=QM?B(S-
MIRRH"!D^G4=: +U%4M4U:QT:S%WJ%PL,)D2(,03EF("@ <DDFJ\GB/3(]6&F
MM,_GF01;O+;RQ(1N"%\;0Q'.,YH U:*RK#Q%IFI7S6EM,[2!69"T3*DH4[6*
M,1AP#@'&<9HN/$>F6NJ+ITLSB<LB,1$Q1&?[BLX&U2W8$\Y'K0!JTR;_ %,G
M^Z?Y5FVOB/3+S4SI\,SF;+A&,;!)"APX1R,,5/4 \5I3?ZF3_=/\J ,KPG_R
M)NB?]>$'_HM:V*Q_"?\ R)NB?]>$'_HM:V* "BBB@ HHHH **** ,KQ-##<^
M&M0@N;PV<,D)5[@9_=@]SCMZ^V:X/PK#;W_A/7--B2&V2$,TEWI$Q2*?(?"_
M[#  ;@">".:]*O+F"RL;BZN6VV\,;22MC.% R>._%9.E:]HTK)9VT,MD'C::
M-)[1[=9%XW%=R@'J"<>M &:L\R?"N)+.3%\VC;H%5OG+"+JHZDUS%P^EK*3I
M#0?\(^?[/_M PG]UDR/NWXXSMV;\]L9KT,7FDS7*W'FP$VR?+/N&Q0V00&Z?
MPG/TJ<W6FPV0F,]I':2GARZA')]^AS0!YQ =*_M2--0-M_PBQO+T6XFQ]FW;
M(\8S\N,^=M[9SBM.6XF_X5=8I=ROO"VS7:NQ\P6QE4,6'7&S.<]LUV4EWIR1
MR13M!%%"VTB8!4!QGC/'0U)->6$!C,]S;1F883>ZCS!Z#/7K^M 'G(.EC6HT
M)M/^$3.IR!0=OV7?]F4X_N[?,W>V[/>MFR ?X5RK<W-U;6[12K'/&C/)'#YC
M!& ') 7;_P !KJK6>QO5N;6!4=+67R98_+PJO@-C!&#PP-1V6N:9?WM_8VMR
MKSZ>P2X3!&PD>IX(X/3T(H \OU*. Z/X@MH/[- ^P"3[7H,I2$JKKQ+'RJOR
M><G*@],5IWWB"<>*K.&QU:Y,0U&&SD6:Z3]XC+@[(@I)'(/F,1R1C-=_%=Z2
MH,<-Q9 ._EE4=/F;^[@=3[5*)+ 7AA#VPNE0,4RN\*.AQUQ0!Y+INHWUGHVF
MV$&L+:VZV]Q*)[N^\G]^)B-I;RVW;1@^7P3NJ[K6I3WC(NIZR8;V*_L5AL8_
MECG0F-BX4C<P+%CN[;<=J]-=K%D&]K8H1YHR5Q_O?KUJK=:SHL!M9I[NU/VB
M86T$@8-N<Y.T$?2@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMIPQ^G6O$?A&UY-XR>'^W+.6*W$DDT<=^\SW+%%0D!@,C<I?/;.* />:***
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MZE)@^[9MP<Y._G(&,=ZZK4[62[LGCBO;BS8<^9!LW=.GS*PQ^%7*9-_J9/\
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MK>VAM84A@B2**-0J(@P% [ =JRO%QQX3U'_KE_45M5A^,#CPGJ'^X/\ T(4
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M2(;^=VV3/!&LLC-P<,1DDYY^M+:^'_"VG74MM::3I%M<7,)22**WC1Y8CU!
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MCV,W_A'M&_Z!=I_WZ%'_  CVC?\ 0+M/^_0K2HH]G#LON#DCV,W_ (1[1O\
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M34UU$2/%\H( &PC=TQGG/>@"2Q\8VUX+=(K2[N9'5'F:VARL =BJELG/.">
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MJ%J8)I6C!.\N[M)C/<N>.U=>B[45?08H 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#,\0W]_IFA7=YIFG-J%Y$A:.V5MI<_Y[5S
MWA[Q/XGUG4=/CO/#"Z=:/"7NII;E&8-M^4(H.>O7/2NFUJ"2YT+4((7"2RVT
MB(Q?8%)4@'=V^M>2?"VTLHM:LUAL/#;SVT;PR7UE?RR32.J#<0K#!SD$X]:
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MUI44 9O]LI_9OVW[#J&W?L\K[,WF_7;UQ[T7&LQVUI;W!LM0D$W1(K9F=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M%+5[G['HM]<^<(/)MWD\TIO"84G.WOCT[UXKX<T_0/%'B"%IH_$2:S>1.\6I
M-''91IM4/E%B(S]Y3@YX/->G?$#69M%\+,\$=J\EW/%9#[7_ *I1*VPLX[@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&CW(AY)WKM_7%:E9GB"[2RT6:XDM5NE5HP86Z-EU&>AZ9S^% &G1110 5F6
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M+927F\?+,0"!LZE<D MGJ>G>L6\^'UW<:'%;1:W/#<I&D> JM$JB82$+N4L
M, #G^%<U?D\+7[7\D(NH#I4U\E_(6!\XN ,KQ\N"R@YXQR,4 7-*\4?VE?6\
M3V$EO;WB2264[2!O."$!LJ/NG!!'7(].E%YXI%KJDL"V,DEG;31075T) /*>
M3&W"]6 W+D\8SWJII?AO5+">S\V>TD@TN&:.Q"[@TA?@&3TPHQQG.<^U+=^&
MM0GU&Z6.XMETZ_N(;FZ!#>8C1[<JG8AMB\G&.>M %FQ\5"\U." V,D5G=O+%
M:71D!\UH\[@5ZJ#AL'G..U;=W/#;VSO/-'$I!&Z1@HS]37-Z;X9O[74;))[B
MW;3=.EFFM@@;S7,F<!\\ *&;IUXZ5T5_:6U[:O'=6T,\8!8)+&'&<=<&@"AX
M2_Y$W0_^O"#_ -%K6Q6/X2_Y$W0_^O"#_P!%K6Q0 4444 %%%% !1110 444
M4 %%%% !02 ,G@5F:MKUAHT1:ZF'F8RL*\NWX5SQBUKQ;(CRB33M*Q]Q6^>4
M>_\ G\ZQG52?+'5]O\^QE*HD^5:LOZKXNA@F-GI<37U]G&U 2J_4U6@\,WFK
M7"W?B*?S<<I;1G"+]?\ /XUO:9HUEI5N(K6!4]6ZD_4UH5*I.6M1W\NG_!%[
M-RUJ:^73_@D5O:P6L2Q01+'&O 51@"I:**Z#8**** "BBB@ HHHH **** "B
MBB@ HHHH *S=>M'O='FMX[I;5F:,B5C@##J?UQC\:TJR_$4%I<Z)-%?7!M[<
MM&6D S@AU(_,@#\: -2BBB@ JA9V]U'JNI333[X)6C,$>XGRP$ ;CMD\U?K-
ML;:*+6-5G2Z$LDS1&2+O$0@ 'XCF@#2HHHH **** *-TUZ-4L%@7-HWF?:#@
M<?+\OZTNJZ9#JUB;>5F1@PDBE3[T4@Y5U/J#_AT-)=PW;ZGI\L,VVWC:3STW
M8W@KA>.^#5Z@#)T34YKD2V&H*L>J6N!,J_=D4_=D7_9;'X'([5K5GWVDQWE[
M:7J2-!=VK?+*G\2'[R,.ZG]" :S?%NM7.C0Z?]FECB-U="%Y'MGN-J[&;A$(
M).5% '145Q-KXUN8])NKF>"&Z-O=O TVX6:A0JD%UE.48EL <YZTX?$.*:R>
M^M=(NY[6.UM[EW#H#^^.$4 GDYZ]J .THKBY_'J6,TUO>6R17HN/)6"6XCB5
M<1([9D8X/WP.W)QCO6CHOBV/7[^.&PL)FMC;I/)<NZA4W;L+C.2<J0<<?G0!
MT=%<IJ>I:W#XHM=,L+ZRE\UO.GB:S;_1K8'EF<2?>)X7Y>3GL#4$OQ!AM[/[
M9-I5VMM-"\UDX92;E5(! &?E."" >HH [*BN/NO'UO8^9;7EG]FU%+CR/L\U
MS&B_<$FXR$[0-I_/BN@T36+?7M(@U&U#"*4'ANH()!&1P>0>1P>M &A1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5B^)/$<'ARS2:2VGNII21%! !N; R3DD   =S6U7+>/-*N-8\//:V^DQ:BQS
MA#/Y4D9Q@,C'C/7N.M %F\\6VME$LLFGZD56#[1<8M\?9H\XR^2/0\+DX!/2
MI'\4V":F+/R[@Q^<MNUV$'DK*R[@A.<Y((YQC) SFN>N=+\426FGZ9=VIO\
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MJCN_P_KU$J=W>>OY"*BJ %4 #L*6BBMS8**** "BBB@ HHHH **** "BBB@
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MCC]S;?\ QJJNEZ3KEQI-I-?>(]3ANY(5::,0VP"N1R,>5ZT =-16)_8FI?\
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MIOI&FR.COI]HS(YD1C"I*N>K#C@^] %J-@T2,%*@@$ C&*=110 4444 %(>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!D<4<081QJ@8[CM&,GUI]%% $?D1>=YWE)YO3?M&[\ZDHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %? H0# 2(  A$! Q$!_\0
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M4?6T_P"^6_QH^U:CZVG_ 'RW^-%% !]JU'UM/^^6_P :/M6H^MI_WRW^-%%
M!]JU'UM/^^6_QH^U:CZVG_?+?XT44 'VK4?6T_[Y;_&C[5J/K:?]\M_C110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "J]__P >$W^[_458JO?_ /'A-_N_U% &[1110 44
M44 %%%% !63K/_'UI?\ U\M_Z*DK6K)UG_CZTO\ Z^6_]%24 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !5>_P#^/";_ '?ZBK%5[_\ X\)O]W^HH W:*** "BBB@ HHHH *R=9_X^M+
M_P"OEO\ T5)6M63K/_'UI?\ U\M_Z*DH 6BBB@ HHHH **** "BBB@ HHHH
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M_GW3_O[_ /6H\RX_Y]T_[^__ %JFHH A\RX_Y]T_[^__ %J/,N/^?=/^_O\
M]:IJ* (?,N/^?=/^_O\ ]:CS+C_GW3_O[_\ 6J:B@"'S+C_GW3_O[_\ 6H\R
MX_Y]T_[^_P#UJFHH A\RX_Y]T_[^_P#UJ/,N/^?=/^_O_P!:IJ* (?,N/^?=
M/^_O_P!:CS+C_GW3_O[_ /6J:B@"'S+C_GW3_O[_ /6H\RX_Y]T_[^__ %JF
MHH A\RX_Y]T_[^__ %J/,N/^?=/^_O\ ]:IJ* (?,N/^?=/^_O\ ]:CS+C_G
MW3_O[_\ 6J:B@"'S+C_GW3_O[_\ 6H\RX_Y]T_[^_P#UJFHH A\RX_Y]T_[^
M_P#UJ/,N/^?=/^_O_P!:IJ* (?,N/^?=/^_O_P!:CS+C_GW3_O[_ /6J:B@"
M'S+C_GW3_O[_ /6H\RX_Y]T_[^__ %JFHH A\RX_Y]T_[^__ %J/,N/^?=/^
M_O\ ]:IJ* (?,N/^?=/^_O\ ]:CS+C_GW3_O[_\ 6J:B@"'S+C_GW3_O[_\
M6H\RX_Y]T_[^_P#UJFHH A\RX_Y]T_[^_P#UJ/,N/^?=/^_O_P!:IJ* (?,N
M/^?=/^_O_P!:CS+C_GW3_O[_ /6J:B@"'S+C_GW3_O[_ /6H\RX_Y]T_[^__
M %JFHH A\RX_Y]T_[^__ %J/,N/^?=/^_O\ ]:IJ* (?,N/^?=/^_O\ ]:CS
M+C_GW3_O[_\ 6J:B@"'S+C_GW3_O[_\ 6H\RX_Y]T_[^_P#UJFHH A\RX_Y]
MT_[^_P#UJ/,N/^?=/^_O_P!:IJ* (?,N/^?=/^_O_P!:CS+C_GW3_O[_ /6J
M:B@"'S+C_GW3_O[_ /6H\RX_Y]T_[^__ %JFHH A\RX_Y]T_[^__ %J/,N/^
M?=/^_O\ ]:IJ* (?,N/^?=/^_O\ ]:CS+C_GW3_O[_\ 6J:B@"'S+C_GW3_O
M[_\ 6H\RX_Y]T_[^_P#UJFHH A\RX_Y]T_[^_P#UJ/,N/^?=/^_O_P!:IJ*
M(?,N/^?=/^_O_P!:CS+C_GW3_O[_ /6J:B@"'S+C_GW3_O[_ /6H\RX_Y]T_
M[^__ %JFHH A\RX_Y]T_[^__ %J/,N/^?=/^_O\ ]:IJ* (?,N/^?=/^_O\
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M.KV=M+_SSDE 8?4=10!KT50TS6M+UF,R:;J%M=J.3Y,@8CZ@=*OT %9.L_\
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M?^^5_P */)D_Y^I?^^5_PJ:B@"'R9/\ GZE_[Y7_  H\F3_GZE_[Y7_"IJ*
M(?)D_P"?J7_OE?\ "CR9/^?J7_OE?\*FHH A\F3_ )^I?^^5_P */)D_Y^I?
M^^5_PJ:B@"'R9/\ GZE_[Y7_  H\F3_GZE_[Y7_"IJ* (?)D_P"?J7_OE?\
M"CR9/^?J7_OE?\*FHH A\F3_ )^I?^^5_P */)D_Y^I?^^5_PJ:B@"'R9/\
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MJKW_ /QX3?[O]17:=9NT444 %<+XY9DUC3FL6U3^TA#)M6RLH[E?*RNXLKD
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MG6?^/K2_^OEO_14E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.L_\?6E_]?+?^BI* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)?644,!@?=Y>7(.=Q&.E0ZSX?N])#3R-&UNTFU&4\G//3M5C3/#NJ)=V%YY
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M.C<O]X?G0 M%)N7^\/SHW+_>'YT +12;E_O#\Z-R_P!X?G0 M5[_ /X\)O\
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MB@"+[+;_ //O%_WP*/LMO_S[Q?\ ? J6B@"+[+;_ //O%_WP*/LMO_S[Q?\
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M_P#S[Q?]\"I:* (OLMO_ ,^\7_? H^RV_P#S[Q?]\"I:* (OLMO_ ,^\7_?
MH^RV_P#S[Q?]\"I:* (OLMO_ ,^\7_? H^RV_P#S[Q?]\"I:* (OLMO_ ,^\
M7_? H^RV_P#S[Q?]\"I:* (OLMO_ ,^\7_? H^RV_P#S[Q?]\"I:* (OLMO_
M ,^\7_? H^RV_P#S[Q?]\"I:* (OLMO_ ,^\7_? H^RV_P#S[Q?]\"I:* (O
MLMO_ ,^\7_? JO?6\"V4K+!$" ,$(..15VJ]_P#\>$W^[_44 ;M%%% !1110
M 4444 %9.L_\?6E_]?+?^BI*UJR=9_X^M+_Z^6_]%24 +1110 4444 %%%%
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MN_U% &[1110 4444 %%%% !63K/_ !]:7_U\M_Z*DK6K)UG_ (^M+_Z^6_\
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M **** "BBB@ HHHH **** "J]_\ \>$W^[_458JO?_\ 'A-_N_U% &[1110
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M?3[M._M&V_Z;_P#@-+_\30!:HJG_ &I:;]FZ;?C.W[-+G'K]VG?VC;?]-_\
MP&E_^)H M45375+1P2K3, 2#BVEZCK_#0^J6D:%W:95'4FVE '_CM %RBJO]
MHVW_ $W_ / :7_XFFG5+164%I@6.%!MI>>_]V@"Y157^T;;_ *;_ /@-+_\
M$TW^U+0N4W3;@ 2/LTN0#_P'V- %RBJO]HVW_3?_ ,!I?_B::FJ6DBAD:9E/
M0BVE(_\ 0: +E%4VU2T099IE&0,FVEZG@?PT[^T;;_IO_P" TO\ \30!:HJG
M_:EIOV;IM^,[?LTN<>OW:=_:-M_TW_\  :7_ .)H M45375+1BP5IB5.#BVE
MX/I]VAM3M$4LS3!0,DFVEP!_WS0!<HJH-2M2 09R#_T[2_\ Q-(=4M%95+3
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MJ:ZG:.H96F92,@BVEP1_WS0VJ6B#+-,HR!DVTO4\#^&@"Y157^T;;_IO_P"
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M>]GTRQU..YN9_)N&B,>.3O3.<$8[$G\ZK^&EM)(;F]MD:*2YD!EAWEEC*C:
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M[QK@$*S=SSGZ,*YJVN[ZX@N$EU*-IK*V41317A"M(I;>[<#<H^4D'(X(K?\
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MJN3W9CR2>:;>Z+97LKSR0EIRN ?-=1QTX!H A\,W%Q<Z)&]RQ>022+YFXD2
M.0&!/)!&"*YG78;JWU"^O)--#7'GI]C<FU6*5<+]X.0Y(.??@8Q77Z79SV6G
M+;W,YFDRQ)!.%!.0H).< <#)SQ6-#X2_L_58=0L+L/)$KKMO(Q(S!BI/[SAL
MC;QDGO0!M74\S:8SI83O)(I7R,IN7/K\P&/HU<YH=I+;>(X6NH!8RM;R!(47
MB897)/[QP-O'8?>KL*B%O MPUPL,8G=0K2!1N('0$]<4 9'B.956UCB;?=K*
M)D@6%I#(J]0=H)4<CG\.<XI_A^:6Y%Y/),@+3 ?95##[.0HROS ')Z] .>/6
MK%YILLM\E]9W0M[D1^4Q>/S$=,Y (R#D'."".IZT_3M.-F]Q/+.9[JY8-+)M
MV@X&  O8 ?4^] ',>)WN[?73/:NUJ&@1))VDD",,O@D*, *V 3U_>#\>JTN6
M2?2;.69'25X$9T?.Y6*@D'/>J=[H%K,LTT$*BZ<[@TDL@7<3R2%8?I5LV)ET
M@6%Q<S2$PB)YU8H['&"V1T)ZT <7 EYI^J6<LFD'^T)+EO-0-:!6C^;YHUW!
MLGCWZYS76:V9Y-.,,%@]TTO5?E*K@@_-EU/Y&J6E>&FT75)+FTN(I(ID2*19
M8 )-J[B#O7&X_-SN!SCK70T <SX7MVM[_4%F06\[)$6M54A4'SX?[[C)Y& 1
M]T<<T_6[OR]6MVM(_M5Q;HPFMQ"[##XVEF53@C:< CG.>P-;\5O! TC0PQQM
M(V^0HH!=O4XZFL^73+I+V>YL+Y;<W!#3)+#YBE@H4,.00< #N.!Q0 [069](
MBD:Z6XWL[!ESA06)V#//R_=YYX[5RGB2>^LM9OI[(R6X95+9ED E<1Y4@*,#
M."F>N5 [BNSTZQ33[00*[2,7:1Y'QEW8EF/' R2>!6;?>'()('-B/(NF.1,T
MLAV9ZL &ZCJ.U &NC.]HK!2KLF0KCH<=#7#:0MSINJZ:&T=TO)%;[9'NM/D^
M4\QA6# 9_3.<FNRO-/2_TUK*::<*ZA6DB<HYQWR*S=%\//H=]<R03PR6]RP9
MPT 212%"CYEP#TYR,]>: )M?%S-:BWM].:[+$,20I08]074YJIX4A^S_ -HQ
MN?+F\Y3);!2!"=@QCYFZCG@_A71U%!;P6RLL$,<2LQ8A%"@D]3QWH YW5;TQ
M:V9K.,7;11&&>+R'98R2&#%T5N<?P^GIGG8T4,-%M-UV+LF,'SQT<'IC^7//
M'-0'2KN">X?3]06WBN)#*Z20>9M<C!*G(QG&><C-6[33H+/3$L$W-"J%26/+
M9ZDD=R23QZT <4MQJ%EX@V0B6*WDOR1;&20EMTN'QQMZ$28Z;6/ISV&N)=2Z
M'>)90I/<M&0D3A2'/I\WR_GQZU4D\/1Q3VSZ>WV;9(&D?S'9BH(.T MCGD'/
M8U;U;28=8MDAFEGC"/O'E/C)]&'1A[&@#G_#Q:SUZ6TM].E2W,*^8SO;&2-\
MG@^6V0N/4'GICFM3Q"MU<1QV]OIC70#!R[A2@ZC&/,4Y_3FI=!T>71+=[02P
M26Q=Y$*0")@S,6(('RD<\8 K7H P?"D0AT^YC+_O!=/YD."!"V%.P99N.AZD
M<]NE9-_>G[1J+V<B_9;G"?;6AD"6K ;20RJ0V#SG(YX)P..P@MX;6$0V\,<,
M2]$C4*!^ K&_L"Y6Q;3(]2VZ:RF/R_(!D6,]4#YQC'&=I..^>: -N,$1J"^\
M@#+>OO10B+'&L:#"J  /0"B@!U%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5X%XGU=(?$7CF>?QCJ>G:CI\D9TJSBOB$D;R@=OE'(8%L#\:
M]]JHVE:<]W]K:PM6N<[O.,*E\^N[&: /+=6^)6MZ;XAT?3M]EYCFQCU"VE@*
MM&TZC<=Q<$D'/W5('<Y.*R-/\>>)=(\.9?4HM0N;K6Y[-IY8E)M I;J&D4?-
MCY064  ]:]KGTZRN9?-GL[>63 7?)$K' .0,D>O--;2]/=)D>QMF2=MTRF%2
M)#ZMQR?K0!D^"-<O?$?A&RU/4((8;J4,'6!PZ':Q7<I!(P<9ZFNAIL<:11K'
M&BHBC"JHP /0"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
